Login
Forian Inc. logo

Forian Inc.

forian.com

No Longer Reporting

The company has not filed an annual or quarterly report since its Q1 FY2026 10-Q, filed May 15, 2026. Its latest SEC filing is a 15-12G from Jun 1, 2026.

The sections below describe the company as of the FY2025 annual report.

What Did They Do?

Provides linked data and analytics products for healthcare and life sciences organizations, including payers and providers, and financial-services investors.

How Did They Make Money?

Health sciences customers are generally invoiced monthly, quarterly or annually for information products, usually made available at a point in time; fees for milestone services are earned as the work is performed.

revenue
SegmentShareRevenue
Health Sciences Revenues
Mix

76%
Financial Services Revenues
Mix

24%

Who Were Their Customers?

Licenses information products to consultants and service providers, and sells directly to healthcare, life sciences and financial-services end users, including investment funds.

Customers above 10% of revenue, FY2025
of revenue from one customer
FY2024: 29% from two customers

Did Revenues Turn Into Profits?

No. It lost $2.9M in FY2025.

Operating income, FY2025
−12% of revenue
▼ −46% (Loss) vs FY2024 (−$7M, −35%)
Net income, FY2025
−9% of revenue
▼ −24% (Loss) vs FY2024 (−$3.8M, −19%)

How Were They Changing?

Since the FY2025 annual report
Latest quarter: Q1 FY2026, the three months to Mar 31, 2026
Revenue
▼ −3%
vs $7.1M in Q1 FY2025
Net income
▲ +199% (Loss)
vs −$1.1M in Q1 FY2025
Health Sciences Revenues share of revenue vs 76.0% in Q1 FY2025
  • May 15, 2026 Forian was acquired and became privately held Parent completed the acquisition; Forian became its wholly owned subsidiary, and its common stock was set to leave Nasdaq.

Grew. Revenue grew 79% in 4 years, from $16.9M in FY2021 to $30.3M in FY2025, about 16% a year.

Financial services added The older report describes life sciences and healthcare customers; the latest report also covers financial-services investors, after the Kyber acquisition expanded the addressable market.

Revenue over time
Health Sciences Revenues Financial Services Revenues
$50M$25M$0

Who Did They Compete With?

Competes with ICON, IQVIA, Veeva Systems, and Definitive Healthcare

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support